Results 11 to 20 of about 403,362 (211)

Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma

eJHaem, 2021
Lymphoplasmacytic lymphoma (LPL) accounts for approximately 2% of hematologic malignancies [1,2] and classically involves the bone marrow and peripheral blood, with less common involvement of the lymph nodes and spleen.
K. Lindholm, Peter A Forsberg, M. Ewalt
semanticscholar   +2 more sources

Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?

PLoS ONE, 2020
Aim Lymphoplasmacytic lymphoma (LPL) is an indolent mature B-cell-neoplasm with involvement of the bone marrow. At least 90% of LPLs carry MYD88-L265P mutation and some of them (~10%) transform into diffuse large B-cell-lymphoma (DLBCL).
Macarena Boiza-Sánchez, R. Manso, O. Balagué, C. Chamizo, E. Askari, R. Salgado, Carlos Blas-López, Elena Aguirregoicoa-García, J. Menárguez, C. Santonja, M. Adrados, M. Limeres-González, M. Piris, S. Rodríguez-Pinilla   +13 more
semanticscholar   +2 more sources

Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series. [PDF]

Clin Case Rep
Management of recurrent or atypical lymphoplasmacytic lymphoma poses a significant therapeutic challenge. Here we demonstrate a case series of three patients with atypical presentations of extranodal lymphoplasmacytic lymphoma that each show remarkable ...
Brown S, Rusbridge J, Follows G, Santarsieri A.   +3 more
europepmc   +2 more sources

Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report. [PDF]

J Med Case Rep
Background Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia rarely transforms into diffuse large B-cell lymphoma, and there have been no reports of cases proving clonal identity when presenting as primary central nervous system lymphoma.
Tanaka Y, Furuya N, Okabe S, Yosizawa S, Katagiri S, Asano M, Suguro T, Moriyama M, Yamada A, Ohtsuki S, Fujimoto H, Akahane D, Gotoh M, Tanigawa M, Matubayashi J, Fukami S, Kohno M, Nagao T, Nakamura N, Gotoh A.   +19 more
europepmc   +2 more sources

A case report of lymphoplasmacytic lymphoma with spherocytosis. [PDF]

Open Life Sci
This article presents a case of a rare lymphoplasmacytic lymphoma (LPL) complicated by spherocytosis in a 74-year-old male. The patient reported progressive fatigue and anemia and had a medical history of type 2 diabetes, hypertension, and cerebral ...
Ma T, Liu T, Yuan B, Wang L, Liu G.
europepmc   +2 more sources

Lymphoplasmacytic lymphoma relapse presenting as isolated multifocal subcutaneous adipose tissue infiltrates on 18F-FDG PET/CT. [PDF]

Acta Radiol Open, 2023
Lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM) is an uncommon mature B cell lymphoma usually involving the bone marrow and, less commonly, the spleen and/or lymph nodes.
Anžej Doma S, Doma A.
europepmc   +2 more sources

Lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia initially presenting as postmenopausal pelvic pain and bleeding: a rare case report with literature review☆ [PDF]

Gynecol Oncol Rep
Background: Lymphoplasmacytic lymphoma / Waldenström macroglobulinemia (LPL/WM) is a rare and indolent low-grade B-cell lymphoproliferative neoplasm that often presents with vague symptoms or asymptomatically.
Dent M, Al-Kawaaz M, Maruthi K, Hawthorne J, Goldsberry W, Spencer C, Al-Quran S.   +6 more
europepmc   +2 more sources

Bilateral auricular lymphoplasmacytic lymphoma: barely mere coincidence. [PDF]

Leuk Res Rep, 2021
We describe the first case of LPL simultaneously involving both auricles. Affected ears were the first manifestation of the disease that led to the diagnosis.
Yavorkovsky LL, Tang Z, Lee ATC.
europepmc   +2 more sources

Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG

EJNMMI Research, 2020
Background In order to study the CXCR4 expression with [68Ga]pentixafor PET in different types of non-Hodgkin lymphoma, we performed a retrospective study to describe the [68Ga]pentixafor PET/CT imaging in a spectrum of lymphomas and to compare it with ...
Qingqing Pan, Yaping Luo, Yan Zhang, Long Chang, Ji Li, Xinxin Cao, Jian Li, Fang Li   +7 more
doaj   +1 more source

Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

EJNMMI Research, 2021
Purpose 68 Ga-pentixafor PET/CT was reported to have a high sensitivity in detecting tumor involvement of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) in our previous study.
Q. Pan, Xin-xin Cao, Yaping Luo, Jian Li, Fang Li   +4 more
semanticscholar   +1 more source